Abstract
Appreciation of the fact that small cell anaplastic carcinoma of the bronchus (SCCB) has almost always metastasised by the time of clinical presentation has focused attention on the role of chemotherapy for this disease. Probably because of its rapid growth rate, SCCB is highly sensitive to several cytotoxic drugs, and the use of combination chemotherapy has significantly improved the duration and quality of survival of these patients. Nevertheless at present only a small percentage of patients obtain long-term survival and there is an obvious need for improvement in therapy to extend the currently attainable median survival. One approach to this is to intensify chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abeloff MD, Ettinger DS, Order SE, Khouri N, Mellits ED, Dorschel NT, Baumgardner R (1981) Intensive induction chemotherapy in 54 patients with small cell carcinoma of the lung. Cancer Treat Rep 65: 639–646
Aisner J, Whitacre M, Van Echo DA, Wiernik PH (1982) Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations. Cancer Treat Rep 66: 221–230
Aisner J, Albert P, Bitran J, Comis R, Daniels J, Hansen H, Ikegami H, Smyth J (1983) Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer Workshop. Cancer Treat Rep 67: 37–43
Aroney RS, Bell DR, Chan WK, Dailey DN, Levi JA (1982) Alternating non-cross-resistant combination chemotherapy for small cell anaplastic carcinoma of the lung. Cancer 49: 2449–2454
Britell JC, Eagan RT, Lee RE (1979) VP-16–213 and cyclophosphamide in small cell lung cancer: a long-term follow-up report. Cancer Treat Rep 63: 2130–2131
Cohen MH (1977) Small cell bronchogenic carcinoma. A prolonged remission following chemotherapy. JAMA 237: 2528
Cohen MH, Creaven PJ, Fossieck BE Jr, Broder LE, Selawry OS, Johnston AV, Williams CL, Minna JD (1977a) Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treat Rep 61: 349–354
Cohen MH, Broder LE, Fossieck BE, Bull M, Ihde DC, Minna JD (1977b) Combination chemotherapy with vincristine, adriamycin and procarbazine in previously treated patients with small cell carcinoma. Cancer Treat Rep 61: 485–487
Daniels JR, Chak L, Alexander M, Kohler M, Friedman M, Torti F, Carter S (1980) Oat cell carcinoma. Alternating compared with sequential combination chemotherapy. Proc Am Assoc Cancer Res/Am Soc Clin Oncol 21: 346
Dombernowsky P, Hansen HH, Sorensen S, osterlind K (1979) Sequential versus non-sequential combination chemotherapy using 6 drugs in advanced small cell carcinoma. A comparative trial including 146 patients. Proc Am Assoc Cancer Res/Am Soc Clin Oncol 20: 277
Edmonson JH, Lagakos SW, Selawry OS, Perlia CP, Bennett JM, Muggia FM, Wampler G, Brodovsky HS, Horton J, Colsky J, Mansour EG, Creech R, Stolback L, Greenspan EM, Levitt M, Israel L, Ezdinli EZ, Carbone PP (1976) Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung. Cancer Treat Rep 60: 925–932
Hande KR, Oldham RK, Fer MF, Richardson RL, Greco FA (1982) Randomised study of high dose versus low dose methotrexate in the treatment of extensive small cell lung cancer. Am J Med 73: 413–419
Hansen HH, Rath M (1979) Lung cancer: epidermoid carcinoma, small cell anaplastic carcinoma, adenocarcinoma and large cell carcinoma. In: Pinedo HM (ed) The EORTC cancer chemotherapy annual 1. Excerpta Medica, Amsterdam, pp 267–291
Hansen HH, Rath M (1980) Lung cancer. In: Pinedo HM (ed) The EORTC cancer chemotherapy annual 2. Excerpta Medica, Amsterdam, pp 267–283
Hansen HH, Selawry OS, Simon R, Carr DT, Van Wyk CE, Tucker RD, Sealy R (1976) Combination chemotherapy of advanced lung cancer. A randomised trial. Cancer 38: 2201–2207
Hansen HH, Dombemowsky P, Hansen M, Hirsch F (1978) Chemotherapy of advanced small cell anaplastic carcinoma: superiority of a four-drug combination to a three-drug combination. Ann Intern Med 89: 177–181
Hansen M, Hansen HH, Dombernowsky P (1980) Long-term survival in small cell carcinoma of the lung. JAMA 244: 247–250
Livingston RB, Mira J for the Southwest Oncology Group (1980) Non-cross-resistant combinations in patients ( PTS) with extensive small cell lung cancer. Proc Am Assoc Cancer Res/Am Soc Clin Oncol 21: 449
Souhami RL, Harper PG, Linch D, Trask C, Goldstone AH, Tobias J, Spiro SG, Geddes DM, Richards JDM (1982) High dose cyclophosphamide with autologous marrow transplantation as initial treatment of small cell carcinoma of the bronchus. Cancer Chemother Pharmacol 8: 31–34
Smyth JF, Ford HT (1981) Methotrexate in the chemotherapy of lung cancer. Cancer Treat Rep (Suppl 1 ) 65: 161–163
Vincent RG, Wilson H, Lane W. Raza S, Chen T (1980) Sequential chemotherapy of small cell carcinoma of lung. Proc Am Assoc Cancer Res/Am Soc Clin Oncol 21: 453
Young JA, Dillman RO, Taetle R, Seagren SL, Royston I, Lehar TJ (1981) Induction chemotherapy, consolidation radiotherapy, and cross-over chemotherapy for small cell carcinoma of the lung ( SCCL ). Proc Am Assoc Cancer Res/Am Soc Clin Oncol 22: 494
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Smyth, J.F., Gregor, A. (1984). Management of Small Cell Cancer: Intensive Chemotherapy. In: Duncan, W. (eds) Lung Cancer. Recent Results in Cancer Research, vol 92. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82218-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-82218-6_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82220-9
Online ISBN: 978-3-642-82218-6
eBook Packages: Springer Book Archive